Review





Similar Products

92
Santa Cruz Biotechnology sc 137220 santa cruz htr7 rabbit
Sc 137220 Santa Cruz Htr7 Rabbit, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htr7/pmc11380450__ijbsv20p4476s1-17-114-115?v=Santa+Cruz+Biotechnology
Average 92 stars, based on 1 article reviews
sc 137220 santa cruz htr7 rabbit - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

90
Jackson Laboratory b6.129-htr7 tm1sut /j ( 5htr7 -ko) mouse
B6.129 Htr7 Tm1sut /J ( 5htr7 Ko) Mouse, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htr7/pmc12255530-157-0-8?v=Jackson+Laboratory
Average 90 stars, based on 1 article reviews
b6.129-htr7 tm1sut /j ( 5htr7 -ko) mouse - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Jackson Laboratory b6.129-htr7^tm1sut/j (5htr7-ko) mice
(A) Schematics showing the proposed autocrine serotonin signaling pathway in a CD8 T cell. Possible pharmacological interventions are indicated. (B and C) Serotonergic gene expression in Sert -WT CD8 T cells in response to antigen stimulation. Naive CD8 T cells were purified from Sert -WT B6 mice and stimulated with anti-CD3 for 3 days. (B) RT-qPCR analyses of 5-HTR family member gene expression at day 1 ( n = 4). Unstimulated naive CD8 T cells were included as a control. (C) RT-qPCR analyses of Sert , Tph1 , and Maoa gene expression over time ( n = 4). (D–H) Serotonergic gene expression in activated Sert -WT and Sert -KO CD8 T cells. (D) Experimental design. Naive CD8 T cells were purified from Sert -WT and Sert -KO B6 mice and stimulated in vitro with anti-CD3 for 1 day. (E–H) RT-qPCR analyses of Tph1 (E), Maoa (F), Htr2b (G), and <t>Htr7</t> (H) expression ( n = 4). (I–M) Autocrine serotonin signaling in Sert -WT CD8 T cells. (I) Experimental design. Sert -WT CD8 T cells were stimulated with anti-CD3 for 3 days in serotonin-depleted medium in the presence or absence of SSRI (FLX or CIT) and/or 5-HTR antagonist (ASE or RS-127445) treatment. ASE, asenapine (a general antagonist of most 5-HTR subtypes); RS-127445, a 5-HTR2B selective antagonist. (J and K) RT-qPCR analyses of Il2 (J) and Ifng (K) expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without ASE treatment ( n = 3). (L) RT-qPCR analyses of Il2 expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without RS-127445 treatment ( n = 3). (M) ELISA analyses of serotonin levels over time in culture supernatants of FLX-treated, CIT-treated, or non-treated (NT) CD8 T cells ( n = 4). (N and O) Western blot analyses of key signaling molecules involved in the 5-HTR-MAPK (N) and TCR (O) signaling pathways. MAPK, mitogen-activated protein kinase. (P–R) Serotonin levels in Sert -WT and Sert -KO BMT mice bearing B16-OVA tumors (denoted as WT and KO, respectively). (P) Experimental design. (Q and R) HPLC analyses of serotonin levels in tumor (Q, n = 4) and serum (R, n = 5–6) at day 21. (S–U) Serotonin levels in Sert -WT mice bearing B16-OVA tumors, with or without SSRI (i.e., FLX) and/or anti-CD8 depletion antibody treatment. (S) Experimental design. (T and U) HPLC analyses of serotonin levels in tumor (T, n = 7–8) and serum (U, n = 4–5) at day 14. Representative of two (B, E–H, J–M, N, and O) and three (C, Q, R, T, and U) experiments. Data are presented as the mean ± SEM. ns, not significant, * p < 0.05, ** p < 0.01, and *** p < 0.001 by Student’s t test (B, E–H, Q, and R), one-way ANOVA (C and M), or two-way ANOVA with Turkey’s multiple comparisons test (J–L, T, and U). See also .
B6.129 Htr7^Tm1sut/J (5htr7 Ko) Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htr7/pmc12255530-349-23-46?v=Jackson+Laboratory
Average 90 stars, based on 1 article reviews
b6.129-htr7^tm1sut/j (5htr7-ko) mice - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Beijing Genomics Institute Shenzhen primers for htr7 and gapdh
(A) Schematics showing the proposed autocrine serotonin signaling pathway in a CD8 T cell. Possible pharmacological interventions are indicated. (B and C) Serotonergic gene expression in Sert -WT CD8 T cells in response to antigen stimulation. Naive CD8 T cells were purified from Sert -WT B6 mice and stimulated with anti-CD3 for 3 days. (B) RT-qPCR analyses of 5-HTR family member gene expression at day 1 ( n = 4). Unstimulated naive CD8 T cells were included as a control. (C) RT-qPCR analyses of Sert , Tph1 , and Maoa gene expression over time ( n = 4). (D–H) Serotonergic gene expression in activated Sert -WT and Sert -KO CD8 T cells. (D) Experimental design. Naive CD8 T cells were purified from Sert -WT and Sert -KO B6 mice and stimulated in vitro with anti-CD3 for 1 day. (E–H) RT-qPCR analyses of Tph1 (E), Maoa (F), Htr2b (G), and <t>Htr7</t> (H) expression ( n = 4). (I–M) Autocrine serotonin signaling in Sert -WT CD8 T cells. (I) Experimental design. Sert -WT CD8 T cells were stimulated with anti-CD3 for 3 days in serotonin-depleted medium in the presence or absence of SSRI (FLX or CIT) and/or 5-HTR antagonist (ASE or RS-127445) treatment. ASE, asenapine (a general antagonist of most 5-HTR subtypes); RS-127445, a 5-HTR2B selective antagonist. (J and K) RT-qPCR analyses of Il2 (J) and Ifng (K) expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without ASE treatment ( n = 3). (L) RT-qPCR analyses of Il2 expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without RS-127445 treatment ( n = 3). (M) ELISA analyses of serotonin levels over time in culture supernatants of FLX-treated, CIT-treated, or non-treated (NT) CD8 T cells ( n = 4). (N and O) Western blot analyses of key signaling molecules involved in the 5-HTR-MAPK (N) and TCR (O) signaling pathways. MAPK, mitogen-activated protein kinase. (P–R) Serotonin levels in Sert -WT and Sert -KO BMT mice bearing B16-OVA tumors (denoted as WT and KO, respectively). (P) Experimental design. (Q and R) HPLC analyses of serotonin levels in tumor (Q, n = 4) and serum (R, n = 5–6) at day 21. (S–U) Serotonin levels in Sert -WT mice bearing B16-OVA tumors, with or without SSRI (i.e., FLX) and/or anti-CD8 depletion antibody treatment. (S) Experimental design. (T and U) HPLC analyses of serotonin levels in tumor (T, n = 7–8) and serum (U, n = 4–5) at day 14. Representative of two (B, E–H, J–M, N, and O) and three (C, Q, R, T, and U) experiments. Data are presented as the mean ± SEM. ns, not significant, * p < 0.05, ** p < 0.01, and *** p < 0.001 by Student’s t test (B, E–H, Q, and R), one-way ANOVA (C and M), or two-way ANOVA with Turkey’s multiple comparisons test (J–L, T, and U). See also .
Primers For Htr7 And Gapdh, supplied by Beijing Genomics Institute Shenzhen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htr7/pm40527447-171-6-10?v=Beijing+Genomics+Institute+Shenzhen
Average 90 stars, based on 1 article reviews
primers for htr7 and gapdh - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
PrimerDesign Inc 5–htr7
(A) Schematics showing the proposed autocrine serotonin signaling pathway in a CD8 T cell. Possible pharmacological interventions are indicated. (B and C) Serotonergic gene expression in Sert -WT CD8 T cells in response to antigen stimulation. Naive CD8 T cells were purified from Sert -WT B6 mice and stimulated with anti-CD3 for 3 days. (B) RT-qPCR analyses of 5-HTR family member gene expression at day 1 ( n = 4). Unstimulated naive CD8 T cells were included as a control. (C) RT-qPCR analyses of Sert , Tph1 , and Maoa gene expression over time ( n = 4). (D–H) Serotonergic gene expression in activated Sert -WT and Sert -KO CD8 T cells. (D) Experimental design. Naive CD8 T cells were purified from Sert -WT and Sert -KO B6 mice and stimulated in vitro with anti-CD3 for 1 day. (E–H) RT-qPCR analyses of Tph1 (E), Maoa (F), Htr2b (G), and <t>Htr7</t> (H) expression ( n = 4). (I–M) Autocrine serotonin signaling in Sert -WT CD8 T cells. (I) Experimental design. Sert -WT CD8 T cells were stimulated with anti-CD3 for 3 days in serotonin-depleted medium in the presence or absence of SSRI (FLX or CIT) and/or 5-HTR antagonist (ASE or RS-127445) treatment. ASE, asenapine (a general antagonist of most 5-HTR subtypes); RS-127445, a 5-HTR2B selective antagonist. (J and K) RT-qPCR analyses of Il2 (J) and Ifng (K) expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without ASE treatment ( n = 3). (L) RT-qPCR analyses of Il2 expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without RS-127445 treatment ( n = 3). (M) ELISA analyses of serotonin levels over time in culture supernatants of FLX-treated, CIT-treated, or non-treated (NT) CD8 T cells ( n = 4). (N and O) Western blot analyses of key signaling molecules involved in the 5-HTR-MAPK (N) and TCR (O) signaling pathways. MAPK, mitogen-activated protein kinase. (P–R) Serotonin levels in Sert -WT and Sert -KO BMT mice bearing B16-OVA tumors (denoted as WT and KO, respectively). (P) Experimental design. (Q and R) HPLC analyses of serotonin levels in tumor (Q, n = 4) and serum (R, n = 5–6) at day 21. (S–U) Serotonin levels in Sert -WT mice bearing B16-OVA tumors, with or without SSRI (i.e., FLX) and/or anti-CD8 depletion antibody treatment. (S) Experimental design. (T and U) HPLC analyses of serotonin levels in tumor (T, n = 7–8) and serum (U, n = 4–5) at day 14. Representative of two (B, E–H, J–M, N, and O) and three (C, Q, R, T, and U) experiments. Data are presented as the mean ± SEM. ns, not significant, * p < 0.05, ** p < 0.01, and *** p < 0.001 by Student’s t test (B, E–H, Q, and R), one-way ANOVA (C and M), or two-way ANOVA with Turkey’s multiple comparisons test (J–L, T, and U). See also .
5–Htr7, supplied by PrimerDesign Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htr7/pmc12147198-0-0-2?v=PrimerDesign+Inc
Average 90 stars, based on 1 article reviews
5–htr7 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
Proteintech rabbit anti htr7 antibody
Figure 1. Restraint stress induced an increase in intestinal 5-HT levels. (a) Changes in 5-HT levels in serum and intestine of mice (n= 5). (b,c) Changes in Tph1 and Tph2 mRNA levels in jejunum and colon tissues of mice (n = 10). (d) EC+ cells in the jejunum and colon were detected by immunohisto- chemistry, and (e,f) the average integrated optical density (IOD) of the positive cells was measured by ImageJ 1.54p (n = 5). (g–i) <t>HTR7</t> immunofluorescence staining and HTR7 cell intensities in jejunum and colon were analyzed by ImageJ. (g–j) The expressions of TPH1, HTR7, SERT and β-actin protein were examined in jejunum and colon by Western blot, and relative protein levels were normalized to β-actin (n = 3) (k,l). Each sample was assayed three times. Data are presented as the mean ± SEM. Differences were assessed by ANOVA and denoted as follows: * p < 0.05; ** p < 0.01; *** p < 0.001 indicate significant difference. C: control group; S: restraint stress; S + PCPA: restraint stress + PCPA; S + IWP-2: restraint stress + IWP-2.
Rabbit Anti Htr7 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htr7/pm40362261-266-13-30?v=Proteintech
Average 93 stars, based on 1 article reviews
rabbit anti htr7 antibody - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Proteintech anti5 ht7r
Figure 1. Restraint stress induced an increase in intestinal 5-HT levels. (a) Changes in 5-HT levels in serum and intestine of mice (n= 5). (b,c) Changes in Tph1 and Tph2 mRNA levels in jejunum and colon tissues of mice (n = 10). (d) EC+ cells in the jejunum and colon were detected by immunohisto- chemistry, and (e,f) the average integrated optical density (IOD) of the positive cells was measured by ImageJ 1.54p (n = 5). (g–i) <t>HTR7</t> immunofluorescence staining and HTR7 cell intensities in jejunum and colon were analyzed by ImageJ. (g–j) The expressions of TPH1, HTR7, SERT and β-actin protein were examined in jejunum and colon by Western blot, and relative protein levels were normalized to β-actin (n = 3) (k,l). Each sample was assayed three times. Data are presented as the mean ± SEM. Differences were assessed by ANOVA and denoted as follows: * p < 0.05; ** p < 0.01; *** p < 0.001 indicate significant difference. C: control group; S: restraint stress; S + PCPA: restraint stress + PCPA; S + IWP-2: restraint stress + IWP-2.
Anti5 Ht7r, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htr7/pm40328340-97-12-15?v=Proteintech
Average 93 stars, based on 1 article reviews
anti5 ht7r - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Proteintech anti 5 ht7r
Figure 1. Restraint stress induced an increase in intestinal 5-HT levels. (a) Changes in 5-HT levels in serum and intestine of mice (n= 5). (b,c) Changes in Tph1 and Tph2 mRNA levels in jejunum and colon tissues of mice (n = 10). (d) EC+ cells in the jejunum and colon were detected by immunohisto- chemistry, and (e,f) the average integrated optical density (IOD) of the positive cells was measured by ImageJ 1.54p (n = 5). (g–i) <t>HTR7</t> immunofluorescence staining and HTR7 cell intensities in jejunum and colon were analyzed by ImageJ. (g–j) The expressions of TPH1, HTR7, SERT and β-actin protein were examined in jejunum and colon by Western blot, and relative protein levels were normalized to β-actin (n = 3) (k,l). Each sample was assayed three times. Data are presented as the mean ± SEM. Differences were assessed by ANOVA and denoted as follows: * p < 0.05; ** p < 0.01; *** p < 0.001 indicate significant difference. C: control group; S: restraint stress; S + PCPA: restraint stress + PCPA; S + IWP-2: restraint stress + IWP-2.
Anti 5 Ht7r, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/htr7/pm40328340-102-26-29?v=Proteintech
Average 93 stars, based on 1 article reviews
anti 5 ht7r - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


(A) Schematics showing the proposed autocrine serotonin signaling pathway in a CD8 T cell. Possible pharmacological interventions are indicated. (B and C) Serotonergic gene expression in Sert -WT CD8 T cells in response to antigen stimulation. Naive CD8 T cells were purified from Sert -WT B6 mice and stimulated with anti-CD3 for 3 days. (B) RT-qPCR analyses of 5-HTR family member gene expression at day 1 ( n = 4). Unstimulated naive CD8 T cells were included as a control. (C) RT-qPCR analyses of Sert , Tph1 , and Maoa gene expression over time ( n = 4). (D–H) Serotonergic gene expression in activated Sert -WT and Sert -KO CD8 T cells. (D) Experimental design. Naive CD8 T cells were purified from Sert -WT and Sert -KO B6 mice and stimulated in vitro with anti-CD3 for 1 day. (E–H) RT-qPCR analyses of Tph1 (E), Maoa (F), Htr2b (G), and Htr7 (H) expression ( n = 4). (I–M) Autocrine serotonin signaling in Sert -WT CD8 T cells. (I) Experimental design. Sert -WT CD8 T cells were stimulated with anti-CD3 for 3 days in serotonin-depleted medium in the presence or absence of SSRI (FLX or CIT) and/or 5-HTR antagonist (ASE or RS-127445) treatment. ASE, asenapine (a general antagonist of most 5-HTR subtypes); RS-127445, a 5-HTR2B selective antagonist. (J and K) RT-qPCR analyses of Il2 (J) and Ifng (K) expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without ASE treatment ( n = 3). (L) RT-qPCR analyses of Il2 expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without RS-127445 treatment ( n = 3). (M) ELISA analyses of serotonin levels over time in culture supernatants of FLX-treated, CIT-treated, or non-treated (NT) CD8 T cells ( n = 4). (N and O) Western blot analyses of key signaling molecules involved in the 5-HTR-MAPK (N) and TCR (O) signaling pathways. MAPK, mitogen-activated protein kinase. (P–R) Serotonin levels in Sert -WT and Sert -KO BMT mice bearing B16-OVA tumors (denoted as WT and KO, respectively). (P) Experimental design. (Q and R) HPLC analyses of serotonin levels in tumor (Q, n = 4) and serum (R, n = 5–6) at day 21. (S–U) Serotonin levels in Sert -WT mice bearing B16-OVA tumors, with or without SSRI (i.e., FLX) and/or anti-CD8 depletion antibody treatment. (S) Experimental design. (T and U) HPLC analyses of serotonin levels in tumor (T, n = 7–8) and serum (U, n = 4–5) at day 14. Representative of two (B, E–H, J–M, N, and O) and three (C, Q, R, T, and U) experiments. Data are presented as the mean ± SEM. ns, not significant, * p < 0.05, ** p < 0.01, and *** p < 0.001 by Student’s t test (B, E–H, Q, and R), one-way ANOVA (C and M), or two-way ANOVA with Turkey’s multiple comparisons test (J–L, T, and U). See also .

Journal: Cell

Article Title: Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

doi: 10.1016/j.cell.2025.04.032

Figure Lengend Snippet: (A) Schematics showing the proposed autocrine serotonin signaling pathway in a CD8 T cell. Possible pharmacological interventions are indicated. (B and C) Serotonergic gene expression in Sert -WT CD8 T cells in response to antigen stimulation. Naive CD8 T cells were purified from Sert -WT B6 mice and stimulated with anti-CD3 for 3 days. (B) RT-qPCR analyses of 5-HTR family member gene expression at day 1 ( n = 4). Unstimulated naive CD8 T cells were included as a control. (C) RT-qPCR analyses of Sert , Tph1 , and Maoa gene expression over time ( n = 4). (D–H) Serotonergic gene expression in activated Sert -WT and Sert -KO CD8 T cells. (D) Experimental design. Naive CD8 T cells were purified from Sert -WT and Sert -KO B6 mice and stimulated in vitro with anti-CD3 for 1 day. (E–H) RT-qPCR analyses of Tph1 (E), Maoa (F), Htr2b (G), and Htr7 (H) expression ( n = 4). (I–M) Autocrine serotonin signaling in Sert -WT CD8 T cells. (I) Experimental design. Sert -WT CD8 T cells were stimulated with anti-CD3 for 3 days in serotonin-depleted medium in the presence or absence of SSRI (FLX or CIT) and/or 5-HTR antagonist (ASE or RS-127445) treatment. ASE, asenapine (a general antagonist of most 5-HTR subtypes); RS-127445, a 5-HTR2B selective antagonist. (J and K) RT-qPCR analyses of Il2 (J) and Ifng (K) expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without ASE treatment ( n = 3). (L) RT-qPCR analyses of Il2 expression in FLX-treated or non-treated (NT) CD8 T cells at day 2, with or without RS-127445 treatment ( n = 3). (M) ELISA analyses of serotonin levels over time in culture supernatants of FLX-treated, CIT-treated, or non-treated (NT) CD8 T cells ( n = 4). (N and O) Western blot analyses of key signaling molecules involved in the 5-HTR-MAPK (N) and TCR (O) signaling pathways. MAPK, mitogen-activated protein kinase. (P–R) Serotonin levels in Sert -WT and Sert -KO BMT mice bearing B16-OVA tumors (denoted as WT and KO, respectively). (P) Experimental design. (Q and R) HPLC analyses of serotonin levels in tumor (Q, n = 4) and serum (R, n = 5–6) at day 21. (S–U) Serotonin levels in Sert -WT mice bearing B16-OVA tumors, with or without SSRI (i.e., FLX) and/or anti-CD8 depletion antibody treatment. (S) Experimental design. (T and U) HPLC analyses of serotonin levels in tumor (T, n = 7–8) and serum (U, n = 4–5) at day 14. Representative of two (B, E–H, J–M, N, and O) and three (C, Q, R, T, and U) experiments. Data are presented as the mean ± SEM. ns, not significant, * p < 0.05, ** p < 0.01, and *** p < 0.001 by Student’s t test (B, E–H, Q, and R), one-way ANOVA (C and M), or two-way ANOVA with Turkey’s multiple comparisons test (J–L, T, and U). See also .

Article Snippet: C57BL/6J (B6), BALB/cJ (BALB/c), B6.SJL- Ptprc a Pepc b /BoyJ (CD45.1), C57BL/6-Tg (TcraTcrb)1100Mjb/J ( OT1 -Tg), B6.129(Cg)- Slc6a4 tm1Kpl /J ( Sert -KO), B6.129- Htr7 tm1Sut /J ( 5Htr7 -KO), and NOD.Cg- Prkdc scid Il2rg tm1Wjl /SzJ (NOD scid gamma or NSG) mice were purchased from the Jackson Laboratory (JAX; Bar Harbor).

Techniques: Gene Expression, Purification, Quantitative RT-PCR, Control, In Vitro, Expressing, Enzyme-linked Immunosorbent Assay, Western Blot, Protein-Protein interactions

Figure 1. Restraint stress induced an increase in intestinal 5-HT levels. (a) Changes in 5-HT levels in serum and intestine of mice (n= 5). (b,c) Changes in Tph1 and Tph2 mRNA levels in jejunum and colon tissues of mice (n = 10). (d) EC+ cells in the jejunum and colon were detected by immunohisto- chemistry, and (e,f) the average integrated optical density (IOD) of the positive cells was measured by ImageJ 1.54p (n = 5). (g–i) HTR7 immunofluorescence staining and HTR7 cell intensities in jejunum and colon were analyzed by ImageJ. (g–j) The expressions of TPH1, HTR7, SERT and β-actin protein were examined in jejunum and colon by Western blot, and relative protein levels were normalized to β-actin (n = 3) (k,l). Each sample was assayed three times. Data are presented as the mean ± SEM. Differences were assessed by ANOVA and denoted as follows: * p < 0.05; ** p < 0.01; *** p < 0.001 indicate significant difference. C: control group; S: restraint stress; S + PCPA: restraint stress + PCPA; S + IWP-2: restraint stress + IWP-2.

Journal: International journal of molecular sciences

Article Title: Restraint Stress Disrupted Intestinal Homeostasis via 5-HT/HTR7/Wnt/β-Catenin/NF-kB Signaling.

doi: 10.3390/ijms26094021

Figure Lengend Snippet: Figure 1. Restraint stress induced an increase in intestinal 5-HT levels. (a) Changes in 5-HT levels in serum and intestine of mice (n= 5). (b,c) Changes in Tph1 and Tph2 mRNA levels in jejunum and colon tissues of mice (n = 10). (d) EC+ cells in the jejunum and colon were detected by immunohisto- chemistry, and (e,f) the average integrated optical density (IOD) of the positive cells was measured by ImageJ 1.54p (n = 5). (g–i) HTR7 immunofluorescence staining and HTR7 cell intensities in jejunum and colon were analyzed by ImageJ. (g–j) The expressions of TPH1, HTR7, SERT and β-actin protein were examined in jejunum and colon by Western blot, and relative protein levels were normalized to β-actin (n = 3) (k,l). Each sample was assayed three times. Data are presented as the mean ± SEM. Differences were assessed by ANOVA and denoted as follows: * p < 0.05; ** p < 0.01; *** p < 0.001 indicate significant difference. C: control group; S: restraint stress; S + PCPA: restraint stress + PCPA; S + IWP-2: restraint stress + IWP-2.

Article Snippet: The tissues were incubated overnight at 4 ◦C with the following primary antibodies: rabbit anti-HTR7 antibody (DF13323, Affinity, OH, USA), rabbit anti-LGR5 (DF2816, Affinity, OH, USA), and rabbit anti-β-catenin (66379-1-Ig, Proteintech, Wuhan, China).

Techniques: Immunohistochemistry, Immunofluorescence, Staining, Western Blot, Control

Figure 4. 5-HT activated Wnt/β-catenin by acting on the HTR7 receptor. The expression of β-catenin and β-actin protein were examined in jejunum (a) and colon (b) by Western blot, and relative protein levels were normalized to β-actin (n = 3). Immunofluorescence staining of β-catenin in Caco2 cells (c) and total and nuclear β-catenin intensities were analyzed by ImageJ (d) (n = 6 hole). 5-HT and SB269970 treated Caco2 cells were used for β-catenin coimmunoprecipitation, input samples from the coimmunoprecipitation assay were analyzed by Western blot (e), and relative protein levels were normalized to β-actin (f) (n = 3). The expressions of TPH1, APC, Axin1, GSK3-β, β-catenin and β-actin protein were examined in jejunum (g) by Western blot, and relative protein levels were normalized to β-actin (h) (n = 3). The expression of β-catenin, TCF3, APC, Axin1, GSK3-β, TPH1, SERT, HTR7 and β-actin protein were examined in colon (i,l) by Western blot, and relative protein levels were normalized to β-actin (j,k,m) (n = 3). Each sample was assayed three times. Data are presented as the mean ± SEM. Differences were assessed by ANOVA and denoted as follows: * p < 0.05; ** p < 0.01; *** p < 0.001 indicate significant difference. C: control group; S: restraint stress; S + PCPA: restraint stress + PCPA; S + IWP-2: restraint stress + IWP-2.

Journal: International journal of molecular sciences

Article Title: Restraint Stress Disrupted Intestinal Homeostasis via 5-HT/HTR7/Wnt/β-Catenin/NF-kB Signaling.

doi: 10.3390/ijms26094021

Figure Lengend Snippet: Figure 4. 5-HT activated Wnt/β-catenin by acting on the HTR7 receptor. The expression of β-catenin and β-actin protein were examined in jejunum (a) and colon (b) by Western blot, and relative protein levels were normalized to β-actin (n = 3). Immunofluorescence staining of β-catenin in Caco2 cells (c) and total and nuclear β-catenin intensities were analyzed by ImageJ (d) (n = 6 hole). 5-HT and SB269970 treated Caco2 cells were used for β-catenin coimmunoprecipitation, input samples from the coimmunoprecipitation assay were analyzed by Western blot (e), and relative protein levels were normalized to β-actin (f) (n = 3). The expressions of TPH1, APC, Axin1, GSK3-β, β-catenin and β-actin protein were examined in jejunum (g) by Western blot, and relative protein levels were normalized to β-actin (h) (n = 3). The expression of β-catenin, TCF3, APC, Axin1, GSK3-β, TPH1, SERT, HTR7 and β-actin protein were examined in colon (i,l) by Western blot, and relative protein levels were normalized to β-actin (j,k,m) (n = 3). Each sample was assayed three times. Data are presented as the mean ± SEM. Differences were assessed by ANOVA and denoted as follows: * p < 0.05; ** p < 0.01; *** p < 0.001 indicate significant difference. C: control group; S: restraint stress; S + PCPA: restraint stress + PCPA; S + IWP-2: restraint stress + IWP-2.

Article Snippet: The tissues were incubated overnight at 4 ◦C with the following primary antibodies: rabbit anti-HTR7 antibody (DF13323, Affinity, OH, USA), rabbit anti-LGR5 (DF2816, Affinity, OH, USA), and rabbit anti-β-catenin (66379-1-Ig, Proteintech, Wuhan, China).

Techniques: Expressing, Western Blot, Immunofluorescence, Staining, Co-Immunoprecipitation Assay, Control